These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10204813)

  • 41. Efficacy of manidipine on circadian blood pressure in essential hypertension.
    Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
    Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.
    Shimamoto K; Hasebe N; Ito S; Kario K; Kimura K; Dohi Y; Kawano Y; Rakugi H; Horiuchi M; Imaizumi T; Ohya Y
    Hypertens Res; 2014 Jan; 37(1):69-75. PubMed ID: 23945965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effects of amlodipine on ambulatory blood pressure in elderly hypertensive patients with different nocturnal reductions in blood pressure.
    Kario K; Shimada K
    Am J Hypertens; 1997 Mar; 10(3):261-8. PubMed ID: 9056682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized prospective crossover trial of amlodipine in pediatric hypertension.
    Rogan JW; Lyszkiewicz DA; Blowey D; Khattak S; Arbus GS; Koren G
    Pediatr Nephrol; 2000 Oct; 14(12):1083-7. PubMed ID: 11045391
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Efficacy and tolerability of two forms of nifedipine in the treatment of hypertension].
    Mukhin NA; Fomina IG; Kozlovskaia LV; Bragina AE; Fomin VV
    Kardiologiia; 2005; 45(4):44-8. PubMed ID: 15940191
    [No Abstract]   [Full Text] [Related]  

  • 47. Remodeling of left ventricular geometry and function induced by lacidipine and nifedipine SR in mild-to-moderate hypertension.
    Sheiban I; Arosio E; Montesi G; Tonni S; Montresor G; Lechi A
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S68-74. PubMed ID: 1726011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension.
    Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N
    Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Restoration of nocturnal dip in blood pressure is associated with improvement in left ventricular ejection fraction. A 1-year clinical study comparing the effects of amlodipine and nifedipine retard on ambulatory blood pressure and left ventricular systolic function in Chinese hypertensive type 2 diabetic patients.
    Ko GT; Chan HC
    Int J Cardiol; 2003 Jun; 89(2-3):159-66. PubMed ID: 12767538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
    Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
    Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nifedipine GITS replacing nifedipine SR: ambulatory blood pressure assessment of efficacy.
    Rahima-Maoz C; Grossman E; Nussinovitch N; Katz A; Rosenthal T
    Cardiology; 1997; 88 Suppl 3():43-6. PubMed ID: 9397293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there any difference between intermediate-acting and long-acting calcium antagonists in diurnal blood pressure and autonomic nervous activity in hypertensive coronary artery disease patients?
    Hoshide S; Kario K; Mitsuhashi T; Ikeda U; Shimada K
    Hypertens Res; 2000 Jan; 23(1):7-14. PubMed ID: 10737129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of two formulations of nifedipine during 24-hour ambulatory blood pressure monitoring.
    Granberry MC; Gardner SF; Schneider EF; Carter IR
    Pharmacotherapy; 1996; 16(5):932-6. PubMed ID: 8888089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of short- and long-acting calcium channel blockers on the relationship between blood pressure and physical activity.
    Kakinoki S; Nomura A; Takechi S; Kitabatake A
    Am J Hypertens; 2001 Jan; 14(1):66-9. PubMed ID: 11206682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.